Arkolith/Insider Trading/SXTP/Form 4

Dow Geoffrey S

President and CEO, Director60 DEGREES PHARMACEUTICALS, INC. (SXTP) · full profile →Form 4 · filed May 21, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)17K$0.22$4K763K
Apr 12, 2024Option exercise(M)68K$0.27$18K746K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)17K—$00
Apr 12, 2024Option exercise(M)68K—$017K
Nov 21, 2023Grant(A)85K—$085K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-045705) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML